Skip to content

908 Devices MASS Business Segments — Cost Of Revenue

Similar metrics at other companies

Iovance Biotherapeutics, Inc. logo
IOVASingle Reportable — Cost Of Revenue
$42.5M-0.5%
Monarch Casino & Resort logo
MCRISingle Reportable — Cost Of Revenue
$10.76M+2.4%
Onto Innovation logo
ONTOSingle Reportable — Cost Of Revenue Excluding12
$114.14M-0.3%
Pool Corporation logo
POOLReportable — Cost Of Revenue
$808.14M+6.5%
Power Integrations logo
POWISingle Reportable — Cost Of Revenues Excluding Stock Based Compensation And Amortization Of Intangible Assets
$50.75M+9.2%
Rambus logo
RMBSReportable — Cost Of Revenue Adjusted
$34.72M+12.1%

Other financials

Income statement

See full
Revenue$13.4M+13.6%
Gross profit$6.9M+24.2%
Operating income-$12.9M-16.9%
Net income-$12.0M-127%
EPS (diluted)-$0.32-126%

Balance sheet

See full
Cash & equivalents$67.6M-14.7%
Total debt$4.5M+18.6%
Total equity$134.2M-15.8%
Total assets$186.7M-4.8%

Cash flow

See full
Operating cash flow$1.2M+108%
CapEx$40.0K-74.8%
Free cash flow$1.2M+108%

Valuation

See full
Market cap$339.57M+29.0%
Enterprise value$276.47M+47.2%
P/S5.9×+0.8×

Profitability

See full
Gross margin51.5%+1.3pp
Operating margin-76.8%-19.6pp
Net margin-62.4%+323pp
FCF margin-16.7%-7.2pp

Returns & leverage

See full
Return on equity-24.6%-149pp
Debt / equity0.0×
Current ratio3.6×-4.0×

Where this comes from

Reported directly by 908 Devices in its filing.

Tagged under the XBRL concept us-gaap:CostOfRevenue.

The official record: 908 Devices’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about 908 Devices's business segments — cost of revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 908 Devices's business segments — cost of revenue?
908 Devices (MASS) reported business segments — cost of revenue of $6.5M in Q1 2026.
How has 908 Devices's business segments — cost of revenue changed year-over-year?
908 Devices's business segments — cost of revenue increased by 4.2% year-over-year, from $6.24M to $6.5M.
What is the long-term trend for 908 Devices's business segments — cost of revenue?
Over 2 years (2023 to 2025), 908 Devices's business segments — cost of revenue has grown at a 5.6% compound annual growth rate (CAGR), from $24.91M to $27.77M.
What does business segments — cost of revenue mean?
This metric captures the direct costs incurred to manufacture and deliver the company's mass spectrometry devices, including materials, labor, and overhead directly attributable to production. Monitoring this allows investors to assess the efficiency of the company's supply chain and production processes. High costs relative to revenue may indicate challenges in manufacturing scalability or pricing pressure.